Astrocytoma, IDH-Mutant, Grade 4 — Trials

Astrocytoma, IDH-Mutant, Grade 4 — Trials · CancerIndex

Clinical trials

Registered studies

16 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 12
Recruiting: 9
Ph III recruiting: 1
Growth YoY: —
Industry share: 8%
Top sponsor: Mayo Clinic
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03434262	SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors	completed	Phase 1	68	St. Jude Children's Research HospitalOTHER	1	May 31, 2024	clinicaltrials

Data updated 23 days agoSource updated May 31, 2024source: clinicaltrials